Tag: COPD
Get active and improve treatment
Last updated: March 19, 2024 © GSK In Germany there are almost three million people who live with a diagnosis of “chronic obstructive pulmonary disease”, or COPD for short.1 Those…
Sanofi: FDA grants priority review to Dupixent for COPD – 02/23/2024 at 09:41
(AOF) – Sanofi announces that the FDA grants priority review to the biologics license application for Dupixent for the treatment of chronic obstructive pulmonary disease (COPD) with type 2 inflammation.…
COPD: what are the promising new treatments for this chronic bronchial disease? A pulmonologist answers: Femme Actuelle Le MAG
This chronic inflammatory disease of the bronchi, characterized by narrowing of the airways, wet cough and difficulty breathing, affects nearly four million French people: 2/3 of patients suffering from COPD…
Sanofi: New positive data in COPD
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Sanofi: new positive data in COPD – 11/27/2023 at 08:18
(CercleFinance.com) – Sanofi reports positive data in the context of a second phase III trial evaluating its Dupixent in COPD (chronic obstructive pulmonary disease), results which make it possible to…
“Tour COPD”, a sporting challenge on a bicycle with respiratory assistance
Ten thousand steps and more. Wednesday, June 28, Philippe Poncet, under respiratory assistance twenty-four hours a day, will try the bet to start cycling for five hours. It should connect…
Sanofi: positive results presented in COPD – 05/22/2023 at 08:05
(CercleFinance.com) – Sanofi announces the presentation of positive results from a phase III trial evaluating the experimental use of its Dupixent in chronic obstructive pulmonary disease (COPD), at the international…
Duxipent increasingly lucrative: Sanofi achieves success in COPD treatment
Duxipent more and more lucrative Sanofi achieves success in COPD treatment 03/23/2023, 5:13 p.m The remedy Dupixent shows success in seven diseases. In the most recent study, all goals in…
Sanofi: positive data for Dupixent in COPD – 03/23/2023 at 09:00
sanofi (photo credit: Adobe Stock / ) (CercleFinance.com) – Sanofi announces that its Dupixent could become the first biological drug against chronic obstructive pulmonary disease (COPD), after a pivotal phase…
Sanofi leads the CAC 40 thanks to the positive results of Dupixent against COPD – 03/23/2023 at 09:18
(AOF) – Largest increase in the CAC 40, Sanofi gained 4.44% to 94.89 euros after announcing that Dupixent could become the first biological drug against chronic obstructive pulmonary disease (COPD).…
Sanofi: Positive data for Dupixent in COPD
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Lungs: six questions about COPD, a disease that affects 4 million French people
Chronic obstructive pulmonary disease (COPD) is a respiratory disease that can seriously impair quality of life. This disease causes people who are affected to experience marked shortness of breath. “Benefit…